Ubs Asset Management Americas Inc Axsome Therapeutics, Inc. Transaction History
Ubs Asset Management Americas Inc
- $417 Billion
- Q4 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 57,642 shares of AXSM stock, worth $7.29 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
57,642
Previous 47,714
20.81%
Holding current value
$7.29 Million
Previous $4.29 Million
13.76%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding AXSM
# of Institutions
351Shares Held
36.3MCall Options Held
1.77MPut Options Held
1.16M-
Rtw Investments, LP New York, NY4.05MShares$512 Million5.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$493 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$417 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA1.47MShares$186 Million24.98% of portfolio
-
Bvf Inc San Francisco, CA1.39MShares$175 Million4.4% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.42B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...